Novo Nordisk A/S | Spese Operative



Operating Expenses Cambiamento Data
Bausch Health Companies USD 2.19B 212M 2024-09
Bristol-Myers Squibb USD 11.55B 1.84B 2024-12
Eli Lilly USD 8.38B 1.53B 2024-12
GlaxoSmithKline GBP 7.42B 402M 2024-12
Merck USD 11.33B 1.4B 2024-12
Novartis USD 11.28B 1.73B 2024-12
Novo Nordisk 37.49B 4.64B 2024-09
Novo Nordisk DKK 37.49B 4.64B 2024-09
Pacira USD 162.55M 145.55M 2024-12
Sanofi EUR 10.07B 969M 2024-09
Supernus Pharmaceuticals USD 152.75M 17.91M 2024-12



Novo Nordisk A/S Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.